Cigna Group (CI)
(Delayed Data from NYSE)
$358.58 USD
+9.74 (2.79%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $358.57 -0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$358.58 USD
+9.74 (2.79%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $358.57 -0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum B VGM
Zacks News
Company News For Oct 6, 2017
by Zacks Equity Research
Companies in the news are: STZ,ISCA,SEAS,CI
UnitedHealth (UNH) Scales a 52-Week High on Recent Deals
by Zacks Equity Research
UnitedHealth's (UNH) shares are riding on its recent acquisition announcements.
3 Value Stocks in Health Insurance to Bet On
by Zacks Equity Research
The Health Insurance industry gains from growing government business, benefits of ACA, business diversification and profit-boosting medical plans despite regulatory hurdles
Cigna Shares (CI) Up 38% This Year: Is Further Upside Left?
by Zacks Equity Research
A mix of factors, ranging from industry to company-specific, are favoring the stock of Cigna (CI), driving solid returns.
Cigna's (CI) Unsecured Debts Receive Ratings From Moody's
by Zacks Equity Research
Unsecured debt ratings of Cigna assigned by Moody's reflect the company's robust business profile and wide national presence.
Why Is Cigna (CI) Up 7.4% Since the Last Earnings Report?
by Zacks Equity Research
Cigna (CI) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cigna (CI) Assigned Shelf Ratings by Moody's, Outlook Stable
by Zacks Equity Research
Shelf ratings of Cigna assigned by Moody's reflect the company' s robust business profile and wide national presence.
CVS Health (CVS) Releases Encouraging Flu Shot Survey Data
by Zacks Equity Research
CVS Health's (CVS) survey on flu vaccination came up with positive outcome. The data confirms untapped opportunities in the flu vaccine market.
Cigna Hits 52-Week High On Strong Q2 Results, Upbeat View
by Zacks Equity Research
Cigna (CI) shares rally to 52-week high as strong second-quarter results, guidance increase and recent developments cheer investors.
Cigna (CI) Earnings Beat in Q2, Guidance Raised, Shares Gain
by Zacks Equity Research
Higher revenues, strength in its Global HealthCare segment and membership growth drive an earnings beat at Cigna (CI) in Q2.
Cigna Corp.'s (CI) Q2 Earnings and Revenues Beat, Guides Up
by Sapna Bagaria
Higher revenues, strength in its Global HealthCare segment and membership growth drive earnings beat at Cigna (CI) in Q2.
3 Reasons Why Cigna Corporation (CI) Is Poised To Beat Earnings
by Jeffrey Hymen
Cigna currently sports a Zacks Rank #2 (Buy) and has defeated its earnings projections in twelve of its past thirteen operational quarters, including an impressive beat last quarter of 13.52%.
Insurance Stocks' Aug 4 Q2 Earnings Roster: BRK.B, CI, AON
by Zacks Equity Research
Core business growth, higher premiums and an improving rate environment are likely to benefit insurers. However, volatile underwriting due to catastrophe losses raises concern.
Should You Buy Cigna Corporation (CI) Ahead of Earnings?
by Zacks Equity Research
Cigna Corporation (CI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP.
Aon plc (AON) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Aon plc's (AON) second-quarter earnings are likely to be driven by strong performance across its five revenue lines.
Top Ranked Growth Stocks to Buy for August 1st
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, August 1st:
Prudential Financial (PRU) Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Higher expenses might restrict Prudential's (PRU) top-line improvement to upset its performance in Q2.
Top Ranked Growth Stocks to Buy for July 26th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 26th:
HCA Healthcare (HCA) Q2 Earnings & Revenues Lag, Stock Dips
by Zacks Equity Research
Earnings miss at HCA Healthcare, Inc. (HCA) can be traced back to an increase in expenses, which outpaced revenue growth.
UnitedHealth (UNH) Beats on Q2 Earnings, Guides Up for 2017
by Zacks Equity Research
Higher revenues, strength in UnitedHealthcare and Optum segments and membership growth drive earnings beat at UnitedHealth Group Inc. (UNH) in Q2.
Why it is Apt to Hold Prudential Financial (PRU) Stock Now
by Zacks Equity Research
Prudential Financial (PRU) continues to impress with its solid product and service portfolio, inorganic growth as well as robust capital and liquidity position.
Visa (V) Gearing Up for Q3 Earnings: Is a Surprise in Store?
by Zacks Equity Research
We expect fiscal third-quarter earnings of Visa Inc. (V) to gain traction from its digital initiatives.
UnitedHealth Faces Moody's Rating Action, Outlook Upgraded
by Zacks Equity Research
UnitedHealth (UNH) rating action by Moody's takes into account the company's its leadership position in the industry, its diversified business product profile.
UnitedHealth (UNH) to Report Q2 Earnings: What to Expect
by Zacks Equity Research
Our proven model does not conclusively show that UnitedHealth (UNH) is likely to beat on earnings this quarter.
MGIC Investment (MTG) Posts Solid June Business Statistics
by Zacks Equity Research
MGIC Investment's (MTG) insurance in force for the month was $187.3 billion, up 5.5% year over year.